Significantly greater 24-h ABP reductions from baseline to week 4 ( primary time point ) were observed with intensive versus moderate treatment ( least-square mean systolic/diastolic BP reduction of -16.2 / -10.1 vs. -9.5 / -6.5 mmHg ; P = 0.0024 / P = 0.010 for least-square mean difference ) .
